search icon
  • Print
  • ShareThis
  • Text Size

IDSA News Releases


Hepatitis C Guidance Website to Develop Section on Cost-Effectiveness of Treatment

An upcoming section on, a website developed by IDSA and AASLD in collaboration with IAS-USA will examine the cost-effectiveness of HCV treatment to help clinicians advise and educate their patients, which is the purpose of the guidance. The new section will not, however, make recommendations regarding the pricing of these therapies for the treatment of HCV.

You Probably Don’t Need These Five Tests or Treatments, Say Infectious Disease Experts

The Infectious Diseases Society of America (IDSA), in partnership with the ABIM Foundation’s Choosing Wisely campaign, has released a list of five tests or treatments that physicians and patients should question.

Infectious Diseases Experts Stress Effectiveness and Safety of Vaccination During Measles Outbreak

We urge parents to ensure that their children are up to date with all recommended immunizations, including with the MMR vaccine, to prevent this devastating disease from causing severe disability and death.

IDSA Applauds Focus on Antibiotic Resistance in President’s FY 2016 Budget Request

IDSA strongly supports the proposal in the President’s Budget Request for Fiscal Year 2016.

| HIVMA | Contact Us

© Copyright IDSA 2015 Infectious Diseases Society of America

Full Site Mobile Site